| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Guy P Nohra is Director at KALV, with reported holdings spanning 3 companies. Guy P Nohra's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $118.9M at current prices.
Guy P Nohra's largest disclosed position is in KALV as Director, worth about $117.3M. Net of sales, the KALV filings show accumulation of 877,500 shares.
Guy P Nohra has 14 Form 4 filings on record from April 2015 to June 2026, across 3 companies: Director at TELA Bio (TELA), 2026; Director at Bioventus (BVS), 2021–2026; Director at KalVista Pharmaceuticals (KALV), 2015.
The 24 reported transactions were 9 option or other derivative awards, 6 option exercises, 4 conversions and 2 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $4.4M and 1 sale worth about $76K.
The only open-market purchase was 877,500 shares of KALV at an average $5.00 on April 14, 2015, about $4.4M.
The only open-market sale was 10,000 shares of BVS at an average $7.57 on December 4, 2025, about $76K.